News by Tag: Cancer Generics Market
Generic Drugs for Prostate Cancer to Escalate Market Growth
March 8, 2013
Patent expiries of prostate cancer drugs are expected to generate significant potential for players operating in the cancer generics sector, says RNCOS.
March 8, 2013
Patent expiries of prostate cancer drugs are expected to generate significant potential for players operating in the cancer generics sector, says RNCOS.
Generic Drugs for Colon Cancer to Boost the Market in Future
August 2, 2012
Patent expiries of colon cancer drugs in future are expected to generate significant potential for the players operating in the cancer generics sector, says RNCOS.
August 2, 2012
Patent expiries of colon cancer drugs in future are expected to generate significant potential for the players operating in the cancer generics sector, says RNCOS.
Cancer Generics Market Analysis
July 11, 2012
RNCOS has recently added a new Market Research Report titled, "Cancer Generics Market Analysis" to its report gallery. This report provides exhaustive information of the global cancer generics market.
July 11, 2012
RNCOS has recently added a new Market Research Report titled, "Cancer Generics Market Analysis" to its report gallery. This report provides exhaustive information of the global cancer generics market.
Global Cancer Generic Drugs Market to Post 26% CAGR in 2011-2015
June 14, 2012
Patent expiries of blockbuster drugs are opening avenues for generic drugs with cancer generics showing prosperous growth in future, says RNCOS.
June 14, 2012
Patent expiries of blockbuster drugs are opening avenues for generic drugs with cancer generics showing prosperous growth in future, says RNCOS.
Cancer Generics Market Analysis
June 11, 2012
RNCOS has recently added a new Market Research Report titled, "Cancer Generics Market Analysis" to its report gallery. This report provides exhaustive information of the global cancer generics market.
June 11, 2012
RNCOS has recently added a new Market Research Report titled, "Cancer Generics Market Analysis" to its report gallery. This report provides exhaustive information of the global cancer generics market.